Robot-assisted vs. Conventional Occupational Therapy of the Upper Limb in Individuals With Cervical Spinal Cord Injury
Recruiting now · Not applicable
Conditions studied: Cervical Spinal Cord Injury
In brief
The goal of this clinical trial is to learn the effects of robot-assisted therapy using the ArmeoSpring on upper limb function compared to conventional occupational therpay in individuals with cervical spinal cord injury (cSCI). The main questions it aims to answer are: \- Which of the two forms of therapy, robot-assisted therapy or conventional occupational therapy, is more effective in terms of improving arm and hand function? The study is designed as a cross-over trial, which means that each participant will receive both therapy forms consecutively, whereas the order is assigned randomly (either robot-assisted therapy first and then occupational therapy, or vice versa). In addition to their clinical routine therapy , participants will: * complete a baseline assessment * practice one therapy form (either robot-assisted or occupational therapy) with one arm for 6 weeks (3 x 30 min per week) * complete a intermediate assessment * practice the other therapy form (either occupational or robot-assisted therapy) with one arm for 6 weeks (3 x 30 min per week) * complete a post assessment * complete a follow-up assessment (if the post assessment was completed prior to 150 days post-injury)
Key facts
- Study ID
- NCT06775925
- Run by
- Swiss Paraplegic Research, Nottwil
- People needed
- 40
- Starts
- 2025-02-01
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-07-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Informed Consent signed by the subject
- Intermediate (>16 days and ≤81 days post-injury) traumatic or non-traumatic cSCI during primary rehabilitation at the Swiss Paraplegic Centre (SPC)
- Neurological level of injury: C1-T1
- American Spinal Injury Association Impairment Scale (AIS): A-D
- Impairment of upper limb function (GRASSP-QtG score unilateral < 25 at baseline t0)
- Ability to sit for 60 minutes and perform training with ArmeoSpring
- Stratification parameters available
You may not qualify if…
- Inability to follow the procedures of the investigation
- Severe concomitant neurological disease
- Concomitant neurodegenerative or progressive diseases
- Impairment of upper limb function due to peripheral nerve lesions
- Severe concurrent medical disease or any other issue that in the opinion of the investigator would confound the results
- Orthopedic limitations of the upper limb
- Device specific contraindications
- Participation in other interventional trials
Where it is running
- Swiss Paraplegic Centre — Nottwil, Canton of Lucerne, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.